Vyvgart Hytrulo Interactions
There are 382 drugs known to interact with Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase), along with 2 disease interactions. Of the total drug interactions, 45 are major, 246 are moderate, and 91 are minor.
- View all 382 medications that may interact with Vyvgart Hytrulo
- View Vyvgart Hytrulo disease interactions (2)
Most frequently checked interactions
View interaction reports for Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase) and the medicines listed below.
- acetaminophen
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- Align (bifidobacterium infantis)
- ambrisentan
- aspirin
- Benlysta (belimumab)
- CellCept (mycophenolate mofetil)
- gabapentin
- Jardiance (empagliflozin)
- levothyroxine
- Lexapro (escitalopram)
- losartan
- Mestinon (pyridostigmine)
- metformin
- mycophenolate mofetil
- Ozempic (semaglutide)
- prednisone
- Repatha (evolocumab)
- ropinirole
- Rystiggo (rozanolixizumab)
- valacyclovir
- Vascepa (icosapent)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vyvgart (efgartigimod alfa)
Vyvgart Hytrulo disease interactions
There are 2 disease interactions with Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase) which include:
More about Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Vyvgart Hytrulo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.